Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Talking therapy boosts HIV treatment success in tanzanian teens

NCT ID NCT05374109

Disease control Sponsor: Duke University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 30, 2026 · Updated 2 times

Summary

This study tested a program called SYV (The Voice of Youth) to see if supporting mental health helps young people with HIV take their medication regularly. 690 youth aged 10-24 in Tanzania took part. The goal was to improve viral suppression by addressing mental health challenges that often lead to missed doses.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

690 people

The number who actually took part.

Started

Mar 2023

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

10 to 24 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Youth between the ages of 10 and 24 years of age * Attending the enrolling adolescent HIV clinic * Are fully disclosed and aware of their HIV status * Receiving ART for a minimum of 6 months * If ≥ 18 years, able to understand the project and provide written informed consent * If \<18 years, a parent or guardian must provide written permission and participant must be able to assent * All adolescents must also commit to attending the 10 weekly SYV sessions and 2 individual sessions Exclusion Criteria: * Active psychosis * Developmental delay, or cognitive disability that precludes active participation in consent process, intervention, and assessment interviews

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adherence, medication are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

HIV infectious disease Medication Adherence Psychological Well-Being

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adherence, medication HIV-1-infection Mental health issue

Contacts and locations

Locations

  • Baylor College of Medicine Children's Foundation - Tanzania, Mbeya Centre for Excellence

    Mbeya, Tanzania

  • Baylor College of Medicine Children's Foundation - Tanzania, Mwanza Centre for Excellence

    Mwanza, Tanzania

  • Bugando Medical Centre

    Mwanza, Tanzania

  • Chronic Disease Clinic of Ifakara Health Institute

    Ifakara, Tanzania

  • Kilimanjaro Christian Medical Centre

    Moshi, Tanzania

  • Mawenzi Regional Referral Hospital

    Moshi, Tanzania

More trials for these conditions

Other studies related to the condition(s) this trial covers.